-
NCHS Data Brief Dec 2023Perinatal mortality(late fetal deaths at 28 completed weeks of gestation or more and early neonatal deaths younger than age 7 days) can be an indicator of the quality of...
Perinatal mortality(late fetal deaths at 28 completed weeks of gestation or more and early neonatal deaths younger than age 7 days) can be an indicator of the quality of health care before, during, and after delivery, and of the health status of the nation (1,2). The U.S. perinatal mortality rate declined 30% from 1990 through 2011, was stable from 2011 through 2016, and declined 4% from 2017 through 2019 (1,3-5). This report describes changes in perinatal mortality, as well as its components, late fetal and early neonatal mortality, from 2020 to 2021, during the COVID-19 pandemic. Also shown are perinatal mortality rates by mother's age, the three largest race and Hispanic-origin groups, and state for 2021 compared with 2020.
Topics: Child; Female; Humans; Infant, Newborn; Pregnancy; Infant Mortality; Pandemics; Perinatal Death; Perinatal Mortality; Stillbirth; United States
PubMed: 38085635
DOI: No ID Found -
JAMA Sep 2023
Topics: Morbidity; Mortality
PubMed: 37750877
DOI: 10.1001/jama.2023.16849 -
BMJ Global Health May 2024
Topics: Humans; Middle East; Health Facilities; Mortality
PubMed: 38760024
DOI: 10.1136/bmjgh-2023-014756 -
Journal of Public Health (Oxford,... Nov 2023Cardiovascular and cancer mortality are the two leading causes of death in the developed world including the USA. However, mortality trends for these diseases are highly...
BACKGROUND
Cardiovascular and cancer mortality are the two leading causes of death in the developed world including the USA. However, mortality trends for these diseases are highly dynamic, and the geographic landscape is in transition. We analyze patterns of mortality improvement at county level during recent decades focusing on mortality decline and geographic diversity.
METHODS
We grouped age-adjusted mortality rates of cardiovascular and cancer diseases from CDC WONDER for 2959 US counties into 3-year time periods to improve reliability. We calculated percent mortality decrease between 1981-83 and 2016-19 for both causes to quantify mortality improvements for counties.
RESULTS
Using standard deviation as an index of disparities, place-based cancer mortalities were 68% larger than cardiovascular disparities. Significantly, 566 US counties had same or higher rates of cancer mortality in 2019 as in 1981. The geographic distribution of mortality improvement in either cause tends to favor largely populated areas along coasts. Less-populated, rural places in the interior and southeastern regions were experiencing less improvement.
CONCLUSIONS
At the county level, large place-based disparities exist for both causes of death with the magnitude of disparities being substantially larger for the reduction in cancer deaths. Put differently, place matters, more for cancer than cardiovascular mortality.
Topics: Humans; Mortality; Neoplasms; Reproducibility of Results; United States; Cardiovascular Diseases; Geography
PubMed: 37395175
DOI: 10.1093/pubmed/fdad089 -
JAMA Feb 2024
Topics: Housing Instability; Mortality
PubMed: 38497705
DOI: 10.1001/jama.2023.27978 -
JAMA Nov 2023
Topics: Maternal Mortality; United States; Humans; Female; Pregnancy
PubMed: 37831458
DOI: 10.1001/jama.2023.19945 -
Journal of Hypertension Aug 2023Estimated pulse wave velocity (ePWV) has been proposed as a potential approach to assess carotid-femoral pulse wave velocity (cfPWV). However, the potential ability of...
Predictive value of estimated pulse wave velocity with all-cause and cause-specific mortality in the hypertensive population: the National Health and Nutrition Examination Surveys 1999-2014.
BACKGROUND
Estimated pulse wave velocity (ePWV) has been proposed as a potential approach to assess carotid-femoral pulse wave velocity (cfPWV). However, the potential ability of ePWV to predict all-cause and cause-specific mortality in the population group with hypertension remains unresolved.
METHODS
We conducted a prospective cohort study using the data of 14 044 adults (age ≥18 years) from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014, and followed this cohort until the end of December 2019. ePWV was calculated by using a regression equation for age and mean blood pressure (MBP), derived by the Arterial Stiffness Collaborative Group.
RESULTS
The weighted mean age of the 14 044 adults included was 54.79 years; 49.42% of all participants were men. During the median follow-up period of 11 years, 3795 deaths were recorded. In the fully adjusted cox regression model, each 1 m/s increase in ePWV was associated with an increased risk of 56% [hazard ratio 1.61; 95% confidence interval (CI) 1.49-1.64] risk for all-cause mortality. Every 1 m/s increase in ePWV resulted in an increased risk of mortality from cardiovascular disease, cerebrovascular disease, respiratory disease, Alzheimer's disease, accidents, cancer, influenza and pneumonia by 60, 70, 47, 118, 73, 41 and 103%, respectively. ePWV has a robust predictive value for 5- and 10-year all-cause mortality in the hypertensive population with AUCs of 0.749 and 0.741, respectively.
CONCLUSION
Elevated ePWV is positively correlated with all-cause mortality and most cause-specific mortalities, independent of traditional risk factors. Moreover, ePWV demonstrates high accuracy in predicting 5-year and 10-year all-cause mortality, outperforming Framingham Risk Score.
Topics: Male; Adult; Humans; Middle Aged; Adolescent; Female; Nutrition Surveys; Cause of Death; Prospective Studies; Pulse Wave Analysis; Carotid Arteries; Hypertension; Risk Factors; Vascular Stiffness; Blood Pressure
PubMed: 37260278
DOI: 10.1097/HJH.0000000000003469 -
The Journal of Investigative Dermatology Jan 2024Vitiligo is a common autoimmune skin disorder; however, there is limited information about risks of mortality among patients with vitiligo. Therefore, we aimed to...
Vitiligo is a common autoimmune skin disorder; however, there is limited information about risks of mortality among patients with vitiligo. Therefore, we aimed to investigate the mortality in patients with vitiligo. A population-based cohort study was conducted using the data linkage of the National Health Insurance Service database and the National Death Registry. Patients with incident vitiligo were matched with sociodemographic factors-matched controls without vitiligo in a 1:5 ratio. All-cause and cause-specific mortalities were compared between patients with vitiligo and controls. In total, 107,424 patients with incident vitiligo and 537,120 matched controls were included. The mortality rates were 34.8 and 45.3 per 10,000 person-years in patients and controls, respectively. Patients with vitiligo showed a significantly lower risk of mortality (adjusted hazard ratio = 0.75, 95% confidence interval = 0.72-0.78). The cause-specific mortality from infectious diseases, oncologic diseases, hematologic diseases, endocrine diseases, neurologic diseases, cardiovascular diseases, respiratory diseases, and renal/urogenital disease was significantly lower in patients with vitiligo. Patients with vitiligo were associated with a lower risk of mortality, suggesting that vitiligo-associated autoimmunity might contribute to reduced morbidity and mortality.
Topics: Humans; Vitiligo; Cohort Studies; Cause of Death; Risk Factors; Republic of Korea
PubMed: 37517513
DOI: 10.1016/j.jid.2023.07.007 -
Scandinavian Journal of Public Health Jun 2024The aim of this study was to investigate associations between having visited the theatre/cinema and an arts exhibition during the past year and all-cause, cardiovascular...
AIMS
The aim of this study was to investigate associations between having visited the theatre/cinema and an arts exhibition during the past year and all-cause, cardiovascular disease (CVD), cancer and other-cause mortality.
METHODS
The 2008 public health postal survey in Scania, Sweden, was distributed to a stratified random sample of the adult population (18-80 years old). The participation rate was 54.1%, and 25,420 participants were included in the present study. The baseline 2008 survey data were linked to cause-of-death register data to create a prospective cohort with 8.3-year follow-up. Associations between visit to the theatre/cinema, visit to an arts exhibition and mortality were investigated in survival (Cox) regression models.
RESULTS
Just over a quarter (26.5%) had visited both the theatre/cinema and an arts exhibition during the past year, 36.6% only the theatre/cinema, 4.9% only an arts exhibition and 32% neither of the two. Not visiting the theatre/cinema during the past year was associated with higher all-cause and CVD mortality. Not visiting an arts exhibition was associated with higher all-cause and other-cause mortality. The combination of having visited neither the theatre/cinema nor an arts exhibition during the past year was associated with higher all-cause, CVD and other-cause mortality.
CONCLUSIONS
Topics: Humans; Adult; Middle Aged; Aged; Sweden; Male; Female; Prospective Studies; Young Adult; Adolescent; Aged, 80 and over; Mortality; Cardiovascular Diseases; Cause of Death; Art; Neoplasms; Culture
PubMed: 37086102
DOI: 10.1177/14034948231165853 -
The Lancet. Public Health Sep 2023
Topics: Humans; Mexico; Mortality, Premature; Socioeconomic Factors
PubMed: 37633671
DOI: 10.1016/S2468-2667(23)00177-9